India to Kenya: Cefixime Export Trade Route

The India to Kenya Cefixime corridor is one of India's established pharmaceutical export routes, with 534 shipments documented worth a combined $8.8M USD. The route is dominated by AFROWAY PHARMA, which alone accounts for roughly 20% of all export value, reflecting the consolidated nature of India's cefixime manufacturing sector.

Across 77 active suppliers, the average shipment value stands at $16.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with cefixime's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 27.9%, placing it at rank #10 among India's top cefixime export destinations globally.

On the import side, key buyers of Indian cefixime in Kenya include LABOREX UGANDA LIMITED, SHANET PHARMACEUTICAL CO LIMITED, SYNER-MED PHARMACEUTICALS(KENYA) and 135 others. LABOREX UGANDA LIMITED is the single largest importer with 25 shipments valued at $706.0K USD.

India's cefixime exports to Kenya are driven primarily by a handful of large-scale manufacturers. AFROWAY PHARMA with 55 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 77 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AFROWAY PHARMA, MICRO LABS LIMITED, THEON PHARMACEUTICALS LIMITED — together account for 41% of total trade value on this route. The average shipment value of $16.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as cefixime capsule 400 mg cefixime capsuleusp 400 mg batch no.r10bc2310 manufacturing dt:oct-23 exp dt:sep-26 245000 nos and cefixime capsule 400 mg cefixime capsuleusp 400 mg batch no.r03bc2504 mfg dt:mar-25 exp dt:feb-28 (494520 pcs), suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LABOREX UGANDA LIMITED is the largest importer with 25 shipments worth $706.0K USD — representing 8% of all cefixime imports from India on this route. A total of 138 buyers are active on this corridor.